Updated: January 13, 2026
Padcev Drug Interactions: What to Avoid and What to Tell Your Doctor
Author
Peter Daggett

- Why CYP3A4 Matters for Padcev Interactions
- Strong CYP3A4 Inhibitors: Drugs to Avoid While on Padcev
- Strong CYP3A4 Inducers: Drugs That May Reduce Padcev's Effectiveness
- Food Interactions: Grapefruit and Grapefruit Juice
- Immunosuppressive Drug Interactions
- Alcohol and Padcev: What Is Known?
- Supplements and Herbal Interactions to Watch
- Hepatic Impairment: Another Drug Interaction Consideration
- What to Tell Your Doctor Before Starting Padcev
Overview
Padcev's active payload (MMAE) is metabolized by CYP3A4. Learn which drugs, supplements, and foods can interact with Padcev and raise your risk of serious side effects.
Is Padcev in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Padcev near you.
When you're being treated with Padcev (enfortumab vedotin-ejfv), the other medications, supplements, and foods you consume can affect how well Padcev works — or increase your risk of dangerous side effects. This is because the active drug payload in Padcev (MMAE) is primarily broken down by an enzyme system in the liver called CYP3A4.
Understanding Padcev's drug interactions is important for your safety. Always give your oncologist a complete list of every medication, supplement, vitamin, and herbal product you take before starting Padcev.
Why CYP3A4 Matters for Padcev Interactions
MMAE (monomethyl auristatin E) — the cytotoxic component of Padcev — is primarily metabolized by the CYP3A4 enzyme system in the liver. Many common medications either inhibit (block) or induce (speed up) this enzyme. When CYP3A4 is blocked, MMAE levels in your body can increase, raising your risk of toxicity. When CYP3A4 is induced, MMAE may be broken down too quickly, potentially making Padcev less effective.
Check live stock now.
Strong CYP3A4 Inhibitors: Drugs to Avoid While on Padcev
The following medications strongly inhibit CYP3A4 and should be avoided or used with extreme caution during Padcev treatment:
Antifungals: Ketoconazole, itraconazole, voriconazole, posaconazole
Antibiotics: Clarithromycin, telithromycin, erythromycin
HIV protease inhibitors: Atazanavir, ritonavir, lopinavir, indinavir
Other strong CYP3A4 inhibitors: Fexinidazole, etrasimod
If you need treatment with any of these drugs during Padcev therapy, contact your oncologist immediately. A dose adjustment or temporary treatment hold may be needed.
Strong CYP3A4 Inducers: Drugs That May Reduce Padcev's Effectiveness
Drugs that strongly induce CYP3A4 can accelerate MMAE breakdown, potentially reducing Padcev's anticancer effect. Use with caution and monitor clinical response:
Prostate cancer drugs: Apalutamide (Erleada), enzalutamide (Xtandi)
Antibiotics/antiparasitics: Rifampin (rifampicin)
Anti-seizure medications: Carbamazepine (Tegretol), phenytoin (Dilantin), phenobarbital
Food Interactions: Grapefruit and Grapefruit Juice
Grapefruit and grapefruit juice are potent CYP3A4 inhibitors. While Padcev is given by IV infusion (not orally), grapefruit compounds are absorbed from the GI tract and can still inhibit CYP3A4 metabolism of MMAE that circulates in the bloodstream after infusion.
Your oncology team may advise you to avoid grapefruit and grapefruit juice during Padcev treatment. Other citrus fruits (oranges, lemons, limes) do not have this interaction.
Immunosuppressive Drug Interactions
Etrasimod (Velsipity), used for ulcerative colitis, can have additive immunosuppressive effects when combined with Padcev. This combination should be avoided or used with extreme caution due to increased infection risk.
Alcohol and Padcev: What Is Known?
There are no formal studies on alcohol's effect on Padcev's pharmacokinetics. However, alcohol can increase liver stress and compromise immune function, which is already challenged by cancer treatment. Patients are generally advised to minimize or eliminate alcohol consumption during Padcev therapy.
Found
Rate
on average
Supplements and Herbal Interactions to Watch
Several herbal supplements can significantly affect CYP3A4 activity:
St. John's Wort: A potent CYP3A4 inducer — avoid completely during Padcev treatment
Milk thistle (silymarin): Some evidence of CYP3A4 modulation — discuss with your oncologist
Curcumin/turmeric supplements: May modulate CYP enzymes — disclose to your oncology team
Never take any new supplement or herbal product without first checking with your oncologist. Many herbal supplements are not regulated and can affect how cancer drugs work.
Hepatic Impairment: Another Drug Interaction Consideration
Padcev should not be used in patients with moderate or severe hepatic impairment (Child-Pugh B or C). Liver disease affects CYP3A4 metabolism of MMAE, increasing toxicity risk. If you are taking other medications that are known to be hepatotoxic (liver-toxic), your care team will monitor your liver enzymes (AST, ALT) closely.
What to Tell Your Doctor Before Starting Padcev
At your pre-treatment appointment, bring a complete medication list including:
All prescription medications, including any new prescriptions from other doctors
Over-the-counter drugs (including antacids, pain relievers, cold medicines)
All vitamins, minerals, and dietary supplements
Herbal products and teas
Any history of grapefruit or grapefruit juice consumption
Also read: Padcev Side Effects: What to Expect and When to Call Your Doctor.
If you need help locating a Padcev infusion center near you, visit medfinder.com.
Frequently Asked Questions
Your oncology team may advise you to avoid grapefruit and grapefruit juice during Padcev treatment. Grapefruit compounds inhibit the CYP3A4 enzyme that metabolizes MMAE (Padcev's payload), potentially increasing MMAE blood levels and toxicity risk. Other citrus fruits like oranges and lemons are generally fine.
Some antifungals are strong CYP3A4 inhibitors and can increase MMAE exposure and toxicity risk. Ketoconazole, itraconazole, and voriconazole should be avoided or used with caution. Fluconazole is a moderate CYP3A4 inhibitor — discuss the risk-benefit balance with your oncologist before use.
No. St. John's Wort is a potent CYP3A4 inducer that accelerates MMAE breakdown, potentially reducing Padcev's effectiveness. It should be avoided completely during Padcev treatment. If you currently take St. John's Wort for depression or mood support, ask your oncologist or primary care doctor about safer alternatives.
Padcev and pembrolizumab (Keytruda) are intentionally used together and have been studied extensively in combination in the EV-302/KEYNOTE-A39 trial. While both drugs have immune-related effects, their combination is well-characterized and is now the FDA-approved first-line standard of care for most patients with locally advanced or metastatic urothelial cancer.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Padcev also looked for:
More about Padcev
39,483 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





